Skip to main content
. 2022 May 3;9:852628. doi: 10.3389/fsurg.2022.852628

Table 3.

Procedural data and in-hospital course.

Acute (n/n) Subacute (n/n) p -value
More than one stent–graft placed 11/130 (8.5%) 18/137 (13.1%) 0.303
Procedure success 247/272 (90.8%) 218/233 (93.6%) 0.329
Emergency conversion 0/576 (0%) 0/379 (0%) n.a
30-day complications 147/718 (20.5%) 65/475 (13.7%) 0.014
   Aortic rupture 4/272 (1.5%) 0/233 (0%) 0.175
   Organ failure 12/588 (2.0%) 6/338 (1.8%) 0.972
   Heart complications 47/446 (10.5%) 20/242 (8.3%) 0.409
   Renal complications 3/142 (2.1%) 1/96 (1.0%) 0.907
   Respiratory complications 48/446 (10.8%) 12/242 (5.0%) 0.015
   Type I endoleak 25/272 (9.2%) 15/233 (6.4%) 0.329
   30-day neurological complications 12/718 (1.7%) 13/475 (2.7%) 0.293
   Spinal cord ischemia 12/576 (2.1%) 13/379 (3.4%) 0.285
   Paraplegia 0/142 (0%) 0/96 (0%) n.a.
   Cerebrovascular disease 20/718 (2.8%) 6/475 (1.3%) 0.119
30-day mortality 33/718 (4.6%) 6/475 (1.3%) 0.004
   Aorta-related mortality 1/142 (0.7%) 0/96 (0%) 1
   Non-aorta-related mortality 1/142 (0.7%) 0/96 (0%) 1

Procedural data and in-hospital course of included studies of systematic literature review and meta-analysis of outcomes of patients with acute and subacute uncomplicated type B aortic dissection (uTBAD) treated by thoracic endovascular aortic repair (TEVAR).